Search

A Susceptible–Exposed–Infected–Removed​ (SEIR) model was developed to forecast the spread of the novel coronavirus (SARS-CoV-2) in the United States and the implications of re-opening and hospital resource utilization. The model relies on the specification of various parameters that characterize the virus and the population being modeled. However, several of these parameters can be expected to vary significantly between states. Therefore, a genetic algorithm was developed that adjusts these population-dependent parameters to fit the SEIR model to data for any given state. Publicly available data was collected from each state in terms of the number of positive COVID-19 cases and the number of COVID-19-caused deaths and used as inputs into a SEIR model to predict the spread of COVID infections in a given population. A genetic algorithm was designed where the genes are the state-dependent parameters from the model. The algorithm operates by determining the fitness of a given set of genes, applying selection, using selected agents to reproduce with cross-over, applying random mutation, and simulating several generations. Use of the genetic algorithm produces exceptionally good agreement between the model and available data. Deviations in the parameters were examined to see if the trends were reasonable. [ABSTRACT FROM AUTHOR]

The article considered that blood supply has shrunk during Covid-19 time period, placing ever greater demands on blood banking professionals throughout the United Sates. Topics include examines that American Red Cross reports that while individuals avoided making donations out of fear of potential exposure to the highly infectious SARS-CoV-2, demand for blood became greater than ever.

The article explores in the United States, for instance, millions of people were vaccinated, cases were falling and people were resuming normal activities. Then came delta. This variant of SARS -CoV-2, the coronavirus that causes COVID-19, hit hard. First spotted in India in October 2020, delta swept quickly around the world, supplanting other versions of the virus.

The article focuses on spark of Omicron variant on financial market and mentions tightened monetary policy in U.S. with slower economic growth in China. Topics discussed include suggest from Jerome Powell, the chairman of the Federal Reserve, for central bank to accelerate plan to taper asset purchases, lack of foreign-exchange reserves and decline in the interest rates.

The article offers information on the mask mandate in schools. Topics include as the Delta variant of the coronavirus leaves schools scrambling at the start of a new year, districts in several states are defying what they see as misguided or ill-founded state laws or orders regarding mask mandates, school accountability and turnaround strategies for low-performing schools, Gov. Ron DeSantis of Florida.

Spring wild turkey (Meleagris gallopavo) hunting is a foundational activity for many hunters across North America. Managing turkey hunters and turkey hunting is, therefore, a priority for state and provincial fish and wildlife management agencies. Early stages of the current SARS‐CoV‐2 (COVID‐19) pandemic in the United States coincided with 2020 spring turkey hunting seasons across the U.S. Potential effects of increases in peoples' time available for hunting on effort and turkey populations could have been substantial. We surveyed the primary wildlife biologist tasked with wild turkey management for each state and provincial jurisdiction with a huntable wild turkey population to determine turkey hunter and hunting dynamics before and during the spring 2020 turkey season. Biologists in 47 states responded to the survey. Results varied among states but hunting license sales, the number of hunters afield, harvest, total hunter‐days afield, and the number of days individual hunters were afield were greater in 2020 than the mean from the previous 3 years (2017–2019) in many states. Although hunting effort and total reported harvest increased in most states in 2020 from the previous 3‐year average, take‐per‐unit‐effort (i.e., harvest per hunter day) decreased in 93% of jurisdictions from which data were available, supporting the finding that increases in turkey harvest in spring 2020 were a result of a COVID‐related increase in participation and effort and not increases in turkey abundance. We recommend using these reference data for turkey population and turkey hunter monitoring pre‐ and post‐pandemic. Monitoring efforts should include wildlife population and habitat evaluations and study of hunter dynamics in a social science framework. [ABSTRACT FROM AUTHOR]

The article focuses on the effectiveness of COVID vaccination in preventing long COVID in children and adolescents. Topics discussed include the prevalence of long COVID in pediatric patients, the association between vaccination and reduced risk of long COVID, and the waning protection over time after vaccination.

A new COVID-19 variant, HV.1, has become the most prevalent strain in the United States, accounting for about a quarter of new cases as of late October. HV.1 is a subvariant of omicron and is closely related to the second most common variant, EG.5. While HV.1 is not believed to cause more severe disease, it is expected to be highly transmissible. The updated coronavirus vaccines are expected to be effective against HV.1, but low vaccine uptake remains a challenge. Experts anticipate a moderate wave of COVID-19 infections in the coming months, particularly as colder temperatures drive people indoors. [Extracted from the article]

The article offers information related to the state of diagnostics labs in the U.S. and expects that testing levels available for wellness exams, chronic disease management and surgeries would return to pre-pandemic levels. Topics discussed include decrease in volume of SARS-CoV-2 testing and the positivity rates on those tests, many basic diagnostic assays involved in the routine of care of patients, and expected increase in demand during the remainder of 2021.

The estimated effectiveness of two doses of Pfizer-BioNTech vaccine in the prevention of multisystem inflammatory syndrome in children was 91%. [ABSTRACT FROM AUTHOR]